Elev8 Research Library
Explore the Science.
Evidence summaries, published research, and regulatory references related to the compounds in the Elev8 catalog.
Human research is presented for scientific and educational context only. Elev8 Health does not recommend that its products be used for anything other than laboratory research purposes, and does not recommend human or veterinary use of any kind.
GHK-Cu
GLOW 70 mg Lyophilized Blend: Component Research
Component research for the GLOW 70 mg lyophilized blend. Exact component identity is governed by the current product specification and COA.
Read Research Brief →
NAD+
NAD+: Cellular Energy, Metabolism and Neurological Research
NAD biology is well established, precursor human research is growing, and direct intranasal NAD+ human outcome data remain limited.
Read Research Brief →
GHK-Cu
GLOW: Exploring Peptide Research in Skin Remodeling and Repair Biology
Component research spanning GHK-Cu skin remodeling, BPC-157 repair models and thymosin-related biology — none of which evaluated the finished GLOW formulation.
Read Research Brief →
KPV
Wolverine: Component Research in Recovery and Inflammatory Pathways
BPC-157, KPV and thymosin-related component research across wound-healing, inflammatory-signaling and cell-migration models.
Read Research Brief →
BPC-157
BPC-157 and Tissue-Repair Research: What the Published Evidence Shows
The BPC-157 literature is dominated by preclinical tissue-repair research. A 2025 systematic review found 35 of 36 included studies were preclinical.
Read Research Brief →
MOTS-C
MOTS-C: Mitochondrial Signaling, Metabolism and Exercise Research
A mitochondrial-derived peptide with substantial preclinical metabolic research and human observational biology — but very limited administered-human data.
Read Research Brief →
Retatrutide
Retatrutide: Triple-Receptor Agonism and Metabolic Research
An investigational triple-receptor agonist with substantial Phase 2 findings and an extensive Phase 3 program — and no FDA approval.
Read Research Brief →
Tirzepatide
Tirzepatide: Dual GIP/GLP-1 Receptor Research
Strong Phase 3 human evidence exists for FDA-approved tirzepatide products — evidence that does not transfer to research material.
Read Research Brief →
Tesamorelin
Tesamorelin: Growth-Hormone-Releasing Hormone Research and Metabolic Biology
Tesamorelin has substantial human clinical research — but that evidence belongs to specific FDA-approved pharmaceutical formulations and indications.
Read Research Brief →
Melanotan I
Melanotan I / Afamelanotide: Melanocortin and Pigmentation Research
Controlled human trials exist for the approved afamelanotide implant in a rare photodermatosis — which is not the same product as a lyophilized research vial.
Read Research Brief →